Treatment approaches and adherence to urate-lowering therapy for patients with gout

References

• KimKYSchumacherHRHunscheEWertheimerAIKongSXA literature review of the epidemiology and treatment of acute goutClin Ther20032561593161712860487
   PubMed Web of Science ®Google Scholar
• Nasser-GhodsiNHarroldLROvercoming adherence issues and other barriers to optimal care in goutCurr Opin Rheumatol201527213413825633242
   PubMed Web of Science ®Google Scholar
• Perez-RuizFTreating to target: a strategy to cure goutRheumatology (Oxford)200948Suppl 2ii9ii1419447780
   PubMed Web of Science ®Google Scholar
• ZhuYPandyaBJChoiHKPrevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008Arthritis Rheum201163103136314121800283
   PubMed Web of Science ®Google Scholar
• WertheimerAMorlockRBeckerMAA revised estimate of the burden of illness of goutCurr Ther Res Clin Exp2013751424465034
   PubMedGoogle Scholar
• KleinmanNLBrookRAPatelPAThe impact of gout on work absence and productivityValue Health200710423123717645677
   PubMed Web of Science ®Google Scholar
• KhannaDFitzgeraldJDKhannaPP2012 American college of rheumatology guidelines for management of gout. part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res (Hoboken)201264101431144623024028
   PubMed Web of Science ®Google Scholar
• Zyloprim® tablet [Package insert]San Diego, CAPrometheus Laboratories Inc2003
   Google Scholar
• JenningsCGMackenzieISFlynnRUp-titration of allopurinol in patients with goutSemin Arthritis Rheum2014441253024560169
   PubMed Web of Science ®Google Scholar
• SchumacherHRBeckerMAWortmannRLEffects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trialArthritis Rheum200859111540154818975369
   PubMed Web of Science ®Google Scholar
• KhannaDKhannaPPFitzgeraldJD2012 American college of rheumatology guidelines for management of gout. Therapy and antiinflammatory prophylaxis of acute gouty arthritisArthritis Care Res (Hoboken)201264101447146123024029
   PubMed Web of Science ®Google Scholar
• SaagKGFitz-PatrickDKopickoJLesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout subjects with inadequate response to standard of care allopurinol (A US-based study)Arthritis Rheumatol201769120321227564409
   PubMed Web of Science ®Google Scholar
• SundyJSBarafHSBYoodRAEfficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment two randomized controlled trialsJAMA2011306771172021846852
   PubMed Web of Science ®Google Scholar
• HussarDANew therapeutic agents marketed in the second half of 2010Pharmacy Today20111736980
   Google Scholar
• WallGCKoenigsfeldCFHeggeKABottenbergMMAdherence to treatment guidelines in two primary care populations with goutRheumatol Int201030674975319590874
   PubMed Web of Science ®Google Scholar
• BeckerMAFitz-PatrickDChoiHKAn open-label, 6-month study of allopurinol safety in gout: the LASSO studySemin Arthritis Rheum201545217418326190562
   PubMed Web of Science ®Google Scholar
• KhannaDKhannaPPHagertyDPatients that continue to flare despite apparent optimal urate lowering therapyArthritis Rheum201264Suppl 10140
   Google Scholar
• DohertyMJansenTLNukiGGout: why is this curable disease so seldom cured?Ann Rheum Dis201271111765177022863577
   PubMed Web of Science ®Google Scholar
• HarroldLRAndradeSEBriesacherBThe dynamics of chronic gout treatment: medication gaps and return to therapyAm J Med20101231545920102992
   PubMed Web of Science ®Google Scholar
• SarawateCABrewerKKYangWGout medication treatment patterns and adherence to standards of care from a managed care perspectiveMayo Clin Proc200681792593416835972
   PubMed Web of Science ®Google Scholar
• HalpernRModyRRFuldeoreMJPatelPAMikulsTImpact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysisCurr Med Res Opin20092571711171919485724
   PubMed Web of Science ®Google Scholar
• MantarroSCapogrosso-SansoneATuccoriMAllopurinol adherence among patients with gout: an Italian general practice database studyInt J Clin Pract201569775776525683693
   PubMed Web of Science ®Google Scholar
• RashidNCoburnBWWuYLModifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare systemJ Rheumatol201542350451225512479
   PubMed Web of Science ®Google Scholar
• OgdieARHochSDunhamJVon FeldtJMA roadmap for education to improve the quality of care in goutCurr Opin Rheumatol201022217318020051863
   PubMed Web of Science ®Google Scholar
• RoddyEZhangWDohertyMConcordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendationsAnn Rheum Dis200766101311131517504843
   PubMed Web of Science ®Google Scholar
• McGowanBBennettKSilkeCWhelanBAdherence and persistence to urate-lowering therapies in the Irish settingClin Rheumatol201635371572125409858
   PubMed Web of Science ®Google Scholar
• BorstadGCBryantLRAbelMPScroggieDAHarrisMDAllowayJAColchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritisJ Rheumatol200431122429243215570646
   PubMed Web of Science ®Google Scholar
• HarroldLRMazorKMVeltenSOckeneISYoodRAPatients and providers view gout differently: a qualitative studyChronic Illn20106426327120675361
   PubMedGoogle Scholar
• BeckerMASchumacherHREspinozaLRThe urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialArthritis Res Ther2010122R6320370912
   PubMed Web of Science ®Google Scholar
• SinghJAChallenges faced by patients in gout treatment: a qualitative studyJ Clin Rheumatol201420317217424662562
   PubMed Web of Science ®Google Scholar
• SpencerKCarrADohertyMPatient and provider barriers to effective management of gout in general practice: a qualitative studyAnn Rheum Dis20127191490149522440822
   PubMed Web of Science ®Google Scholar
• VaccherSKannangaraDBaysariMBarriers to care in gout: from prescriber to patientJ Rheumatol201643114414926568590
   PubMed Web of Science ®Google Scholar
• Jimenez-LinanLMEdwardsLAbhishekAOnline patient information resources on gout provide inadequate information and minimal emphasis on potentially curative urate lowering treatmentArthritis Care Res (Hoboken) Available from: https://www.ncbi.nlm.nih.gov/labs/articles/27390083/Accessed March 6, 2017
   Google Scholar
• BriesacherBAPhDAndradeSEScDFouayziHChanAComparison of drug adherence rates among patients with seven different medical conditionsPharmacotherapy2009284437443
   Web of Science ®Google Scholar
• SinghJAFacilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyArthritis Res Ther2014162R8224678765
   PubMed Web of Science ®Google Scholar
• PaulusHESchlossteinLHGodfreyRGKlinenbergJRBluestoneRProphylatic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patientsArthritis Rheum19741756096144606955
   PubMed Web of Science ®Google Scholar
• YuTGutmanAEfficacy of colchicine prophylaxis. Prevention of recurrent gouty arthritis over a mean period of 5 years in 208 gouty subjectsAnn Intern Med19615517919113787543
   PubMed Web of Science ®Google Scholar
• BeckerMASchumacherHRWortmannRLFebuxostat compared with allopurinol in patients with hyperuricemia and goutN Engl J Med2005353232450246116339094
   PubMed Web of Science ®Google Scholar
• WortmannRLMacdonaldPAHuntBJacksonRLEffect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trialsClin Ther201032142386239721353107
   PubMed Web of Science ®Google Scholar
• RichettePDohertyMPascualEUpdated EULAR evidence-based recommendations for the management of goutAnn Rheum Dis20147311424092418
   PubMed Web of Science ®Google Scholar
• ReesFJenkinsWDohertyMPatients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational studyAnn Rheum Dis201372682683022679303
   PubMed Web of Science ®Google Scholar
• Márquez-ContrerasEMartell-ClarosNGil-GuillénVEfficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA studyJ Hypertens200624116917516331115
   PubMed Web of Science ®Google Scholar
• GoldfienRDNgMSYipGEffectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot studyBMJ Open201441e003627
   Web of Science ®Google Scholar
• FieldsTRRifaatAYeeAMFPilot study of a multidisciplinary gout patient education and monitoring programSemin Arthritis RheumIn press2016
   Web of Science ®Google Scholar
• ConnVSRupparTMChaseJAEnriquezMCooperPSInterventions to improve medication adherence in hypertensive patients: systematic review and meta-analysisCurr Hypertens Rep201517129426560139
   PubMed Web of Science ®Google Scholar
• LiuXLewisJJZhangHEffectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trialPLoS Med2015129118
   Web of Science ®Google Scholar
• ChoiHKAtkinsonKKarlsonEWCurhanGObesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up studyArch Intern Med2005165774274815824292
   PubMed Web of Science ®Google Scholar
• AuneDNoratTVattenLBody mass index and the risk of gout: a systemic review and dose-response meta-analysis of prospective studiesEur J Nutr20145381591160125209031
   PubMed Web of Science ®Google Scholar
• MiaoZLiCChenYDietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern ChinaJ Rheumatol20083591859186418634142
   PubMed Web of Science ®Google Scholar